ESSA Pharma Inc.

De la TradeVille.ro wiki
Versiunea din 21 septembrie 2024 15:42, autor: 127.0.0.1 (discuție) (The LinkTitles extension automatically added links to existing pages (https://github.com/bovender/LinkTitles).)
(dif) ← Versiunea anterioară | Versiunea curentă (dif) | Versiunea următoare → (dif)

Pagina dedicata companiei ESSA Pharma Inc. listata cu simbolul CA.EPI

Descriere companie

ESSA Pharma Inc. (www.essapharma.com) is a Canada-based clinical-stage pharmaceutical company. The Company is focused on developing therapies for the treatment of prostate cancer. The Company’s lead candidate, EPI-7386 is an oral, small molecule that inhibits the androgen receptor (AR) through a novel mechanism of action (N-terminal domain inhibition). The Company is evaluating EPI-7386 as a monotherapy for the treatment of adult male patients with metastatic castration-resistant prostate cancer (mCRPC) resistant to standard-of-care treatments.

Grafic actiuni companie

Ultimele stiri despre ESSA Pharma Inc. (CA.EPI)

Adus de la „https://wiki.tradeville.ro/index.php?title=ESSA_Pharma_Inc.&oldid=444007”